Previous Article | Next Article 
Journal of Virology, April 1999, p. 3449-3454, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human Immunodeficiency Virus Type 1 Derived from Cocultures of
Immature Dendritic Cells with Autologous T Cells Carries
T-Cell-Specific Molecules on Its Surface and Is Highly
Infectious
Ines
Frank,1
Laco
Kacani,1
Heribert
Stoiber,1
Hella
Stössel,2
Martin
Spruth,1
Franz
Steindl,3
Nikolaus
Romani,2 and
Manfred
P.
Dierich1,*
Institute for Hygiene and Ludwig Boltzmann
Institute for AIDS Research1 and
Department of Dermatology,2
University of Innsbruck, Innsbruck, and Institute for Applied
Microbiology, University of Agriculture,
Vienna,3 Austria
Received 16 September 1998/Accepted 5 January 1999
 |
ABSTRACT |
During the budding process, human immunodeficiency virus type 1 (HIV-1) acquires cell surface molecules; thus, the viral surface of
HIV-1 reflects the antigenic pattern of the host cell. To determine the
source of HIV-1 released from cocultures of dendritic cells (DC) with T
cells, immature DC (imDC), mature DC (mDC), T cells, and their
cocultures were infected with different HIV-1 isolates. The
macrophage-tropic HIV-1 isolate Ba-L allowed viral replication in both
imDC and mDC, whereas the T-cell-line-tropic primary isolate PI21
replicated in mDC only. By a virus capture assay, HIV-1 was shown to
carry a T-cell- or DC-specific cell surface pattern after production by
T cells or DC, respectively. Upon cocultivation of HIV-1-pulsed DC with
T cells, HIV-1 exclusively displayed a typical T-cell pattern.
Additionally, functional analysis revealed that HIV-1 released from
imDC-T-cell cocultures was more infectious than HIV-1 derived from
mDC-T-cell cocultures and from cultures of DC, T cells, or peripheral
blood mononuclear cells alone. Therefore, we conclude that the
interaction of HIV-1-pulsed imDC with T cells in vivo might generate
highly infectious virus which primarily originates from T cells.
 |
TEXT |
Dendritic cells (DC) are the most
competent antigen (Ag)-presenting cells in vivo (1, 7,
24). During the immature developmental state, DC are well
equipped to capture Ag. Maturation of DC is reflected by an enhanced
expression of costimulatory and accessory molecules
like CD80, CD86, CD40, and CD54 (1). During this
differentiation and maturation state, DC migrate from the periphery via
the afferent lymph to the T-cell areas in secondary lymphoid organs
where T-cell activation can occur (1, 19, 23).
There is substantial evidence that immature DC (imDC), which are
present in the skin and mucosal surfaces, e.g., Langerhans cells, are
directly involved in the transmission of human immunodeficiency virus
type 1 (HIV-1) to CD4+ T cells (4, 5, 28, 29,
31). In this respect, DC appear to be unique since monocytes
(Mo), macrophages, B cells, and T cells pulsed in a similar manner fail
to induce high levels of infection upon coculture with T cells (3,
6, 28, 31, 39). In vivo studies in rhesus monkeys have shown that
DC might be an important carrier of simian immunodeficiency virus from skin or mucosal surfaces to lymph nodes (20, 37). The
presence of productively infected DC-derived syncytia (multinucleated
giant cells) at the mucosal surface of adenoids (14) and in
T-cell-rich areas of lymph nodes (13) further underlines the
importance of DC in HIV infection.
Considerable effort has been made to model the primary HIV infection in
vitro by exposing DC derived from skin or blood (4) or from
proliferating (3, 4, 9, 41) or nonproliferating (3, 16,
17, 34, 40) precursors to HIV-1. Depending on the type of DC used
for infection, controversial results were obtained concerning viral
replication in these cells (4). The ability to generate DC
from CD14+ human blood monocytes in the presence of
cytokines (monocyte-derived DC [MDDC]) provides an opportunity to
induce the DC phenotype in different stages of maturation (2, 8,
26, 27, 32, 33, 42).
In contrast to infection of DC, consistent results demonstrated
vigorous viral replication when DC pulsed with HIV-1 were subsequently
cocultured with T cells (3, 5, 30, 40). Presently, it is not
known whether DC, T cells, or a putative fusion product resulting from
DC-T-cell conjugates (18, 29, 31) is the primary site of
viral replication. Furthermore, the involvement of T cells in the
generation of multinucleated giant cells in vivo is still unclear.
To analyze the main source of viral replication in DC-T-cell
cocultures and to prove productive infection of DC, phenotypic analysis
of virions was performed by a virus capture assay (VCA). Since during
the budding process HIV-1 incorporates host cell membrane-derived
molecules (10, 12, 38) into its envelope
in addition to the
viral glycoproteins gp41 and gp120 (15)
the surface pattern
of HIV-1 reflects the Ag pattern of the host cell and is therefore a
footprint of its origin (12, 38). Thus, phenotypic analysis
of HIV-1 should identify the major source of HIV-1 virions in
DC-T-cell cocultures.
(This work is part of the Ph.D. thesis of I. Frank.)
Generation and characterization of MDDC.
DC used in this study
were generated from CD14+ Mo (>98%) in the presence of
interleukin-4 (IL-4) (1,000 U/ml) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (800 U/ml) as described recently (2, 35). To remove possible contaminations with T cells, DC
were further purified on day 5 by cell sorting as large
CD2
and CD3
cells. Purified cells were
cultured for two more days in complete RPMI 1640 (RPMI 1640-10% fetal
calf serum-5% L-glutamine [cRPMI]) in the presence of
penicillin-streptomycin (100 IU of each), IL-4 (1,000 U/ml), and GM-CSF
(800 U/ml). Full maturation was achieved by addition of Mo-conditioned
medium (20%) (2, 32) and tumor necrosis factor alpha
(TNF-
; 1,000 U/ml) on day 5 for an additional 48 h.
Fluorescence-activated cell sorting (FACS) analysis revealed a typical
imDC or mature DC (mDC) phenotype as described previously (1,
22). Molecules such as B7.2, HLA class II, and intercellular adhesion molecule 1 (ICAM-1) were found to a higher extent on mDC,
while CD4, CD11b, CD11c, and CD43 were less well expressed on mDC (data
not shown). Expression of CXCR4 (with monoclonal antibody [MAb] 12G5)
was too low for detection by FACS analysis. In contrast, chemokine
receptor 5 (clone MAb 2D7) was found to be up-regulated during
maturation. imDC and mDC were found to be negative for the T-lymphocyte
markers CD5 and CD3 as well as for the monocytic marker CD14, the
receptor for lipopolysaccharide (data not shown).
Productive infection of imDC and mDC by HIV-1Ba-L.
Initially, the replication of macrophage-tropic (M-tropic) and
T-cell-line-tropic (T-tropic) HIV-1 isolates in imDC and mDC generated
from CD14+ Mo was examined and compared to virus production
in T cells and cocultures of HIV-1-infected DC with T cells. The
ability of both isolates (Ba-L and IIIB) to replicate in these cells
was determined by p24 Ag enzyme-linked immunosorbent assay (ELISA)
(Fig. 1). DC were exposed to HIV-1 (2 ng
of p24 Ag/100 µl/106 cells). After incubation for
1.5 h at 37°C, cells were washed three times to remove unbound
virus and were cultured for 14 days in cRPMI containing IL-4 (1,000 U/ml) and GM-CSF (800 U/ml). For cocultures, HIV-1-pulsed DC were
subsequently added to unstimulated, uninfected syngeneic T cells (1:2)
without additional cytokines. T cells were enriched by depletion of B
cells on a nylon wool column (>97% purity) and checked by FACS
analysis with anti-CD3, anti-CD19, and anti-CD14 MAbs. Purified T cells
were grown and maintained in cRPMI supplemented with IL-2 (20 U/ml).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Replication of HIV-1Ba-L in DC, T cells, and
DC-T-cell cocultures. At different time points after exposure of cells
to HIV-1, aliquots of culture supernatants were assayed for p24 Ag. (A
and B) imDC (A) or mDC (B) were harvested on day 7 and pulsed with
HIV-1Ba-L (2 ng of p24 Ag for 106 cells) for 90 min at 37°C. After incubation, cells were washed three times to
remove unbound virus and were cultured in the presence of IL-4 and
GM-CSF. (C) T cells were isolated from PBMC by nylon wool column
separation and stimulated with IL-2 (20 U/ml) for 48 h prior to
infection with HIV-1Ba-L; infection was performed as
described for DC. T cells were cultivated in the presence of IL-2 (20 U/ml). (D and E) imDC (D) or mDC (E) (5 × 105) were
exposed to HIV-1Ba-L as described for panels A and B and
cocultured with T cells (5 × 105) without adding
further cytokines. Results are given as means ± standard errors
of the means of four (T cells and imDC) or six (mDC) independent
experiments. (F) mDC were pulsed and cultivated with the T-tropic
primary isolate PI21 as described for panels A and B. Means ± standard errors of the means of three independent experiments are
shown.
|
|
In five of six independent experiments, productive infection, as
measured by p24 Ag production, was observed for imDC and mDC pulsed
with the M-tropic HIV-1 isolate Ba-L (Fig. 1A and B). No virus was
released from DC with use of the T-tropic HIV-1 strain IIIB for
infection, although the same amount of virus was able to infect primary
T cells and T-cell lines (data not shown). The amount of
HIV-1Ba-L produced by imDC and mDC differed only slightly in comparison to that by T cells (Fig. 1A to C). However, in DC-T-cell cocultures (Fig. 1D and E) viral replication started at an earlier time
and was usually up to three times higher than that with DC or T-cell
cultures (Fig. 1A and D and B and E). In contrast to imDC, mDC pulsed
with the primary isolate PI21, which induced syncytia on MT-2 cells but
did not infect macrophages, resulted in a p24 Ag concentration
comparable to that for infection of imDC by the HIV-1Ba-L
isolate (Fig. 1A and F).
During the course of infection, mDC did not change their phenotype
while imDC acquired an intermediate phenotype which still
significantly
differed from mDC. This effect was not HIV-1 specific,
since the same
phenotype was observed in the case of imDC pulsed
with the supernatant
of IL-2-stimulated peripheral blood mononuclear
cells (PBMC), too (data
not
shown).
It was reported previously that in cocultures viral replication
occurred independently of virus strain and viral tropism (
3,
16,
30,
39,
40). In our study, virus replication in imDC
and mDC
occurred with M-tropic virus only. Observed results are
in accordance
with data obtained by A. Granelli-Piperno, who also
reported productive
infection of imDC (
16) and mDC (
15a) with
M-tropic isolates. A preferential infection of DC with M-tropic
isolates might be due to substantial expression of chemokine receptor
5 on imDC and on mDC. In contrast, the expression of CXCR4, the
main
coreceptor for T-tropic HIV-1 strains (
11), was too low
for
detection by FACS analysis. However, lack of CXCR4 expression
on MDDC
has not been reported by others (
34), and there is still
disagreement whether MDDC might be productively infected by T-tropic
virus (
3,
16,
17,
34,
40). These discrepancies might
be due
to the type or DC used for infection, different purification
methods,
and/or stimuli used to obtain an mDC phenotype (
16,
17,
30,
34).
In our study, mDC were shown to be productively infected with the
primary syncytium-inducing HIV-1 isolate PI21, while no
infection was
achieved with HIV-1
IIIB. Recently, productive infection
of
MDDC independent of CXCR4 by T-tropic isolates and primary
syncytium-inducing isolates was reported (
34,
36). HIV-1
entry
was inhibited by the

-chemokine SDF-1, the natural ligand of
CXCR4, but not by the anti-CXCR4 MAb 12G5. Therefore, an SDF-1
receptor
on MDDC was postulated (
34,
36), different from CXCR4,
which
functions as coreceptor for some T-tropic isolates or primary
HIV-1
strains.
Phenotypic analysis of HIV-1.
To characterize the surface
pattern of HIV-1 virions, supernatants containing virus were used to
examine the presence of host cell-derived molecules by a VCA. Virus
propagated in imDC or mDC, T cells, or DC cocultures with T cells was
screened for the presence of adhesion molecules and activation markers
including cell-type-specific Ag.
For VCA, virus-containing culture supernatants were purified by
centrifugation (750 ×
g) and filtration (0.22-µm
pore size)
to remove cell debris. The assay was performed as described
earlier
(
12,
25) with slight modifications. Briefly,
immunoglobulin
(Ig) (rabbit anti-mouse IgG; 200 ng/100 µl in 100 mM
NaHCO
3, pH
9.5)-precoated microtiter plates were incubated
with MAbs (250
ng/50 µl/well) directed against different cell Ags.
After an incubation
of 4 h at room temperature, plates were washed
and unspecific
binding was blocked (phosphate-buffered saline
[PBS]-3% bovine
serum albumin for 40 min at room temperature).
Virus-containing
supernatants (400 pg/50 µl/well) were added and
incubated overnight
at 4°C. Unbound virus was removed while antibody
(Ab)-captured
virus was lysed (PBS-1% Nonidet P-40, 50 µl/well) to
release the
viral core protein p24. After virolysis, the amount of p24
Ag
was determined by ELISA. Nonspecific binding of HIV-1 to Ig was
determined by unspecific isotype controls. The presence of gp120
(MAb
2G12) was detected in every experiment independent of the
virus source
(data not shown). To confirm that HIV-1 bound to
Ig-immobilized Ab
instead of cell vesicles, transmission electron
microscopic studies
were performed. Ultrastructural analysis of
vertical sections of three
independent experiments revealed neither
a contamination with cell
vesicles nor clumping of virions. Additionally,
this method allowed us
to exclude the presence of p24 Ag in cell
vesicles which might cause
false-positive signals in the VCA.
No virus was captured by isotype
controls.
As shown in Fig.
2A, the phenotypic
comparison of virions released from imDC or mDC exhibited some
important differences:
CD1a, expressed on imDC and less frequently on
mDC, was found
on virions derived from imDC but not on virions from
mDC. In contrast,
CD83, a DC-specific maturation marker, was detected
on virions
released from mDC only. Cell surface markers such as CD40,
CD43,
CD54, CD55, HLA-DR, and HLA-DQ Ag were present on the virions
from imDC and mDC in similar amounts. The signal for CD4 in the
capture
assay was negative. No virus was captured by using Ab
directed against
molecules which were not expressed on the host
cell, like the T-cell
markers CD3, CD5, and CD25; the monocytic
marker CD14; or the B-cell
marker CD19 (data not shown). The absence
of CD3 and CD14 on DC-derived
virions indicated that replication
of HIV-1 occurs in DC and excluded
the possibility that contaminating
T cells or Mo are the site of HIV-1
production.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 2.
Phenotypic characterization of HIV-1Ba-L
derived from DC, T cells, and DC-T-cell cocultures.
HIV-1Ba-L released from various cell culture supernatants
was analyzed for the presence of cell surface Ag listed on the
x axis. For VCA, IgG-precoated microtiter plates were
incubated with MAbs directed against different cell surface Ags
including isotype controls (5 µg/ml) prior to overnight incubation at
4°C with HIV-1Ba-L-containing supernatants (8 ng/ml).
Unbound virus was removed, and Ab-captured virus was lysed (PBS-1%
Nonidet P-40, 50 µl/well). After virolysis, the amount of p24 Ag was
determined by ELISA. The virus binding capacity of the VCA was about
15% of input virus; data represented in bar graphs were calculated as
follows: sample (isotype control + 3 × standard
error of the mean). Bars represent means ± standard errors of the
means of duplicates of three independent experiments. (A) imDC or mDC
were pulsed with HIV-1Ba-L as described for Fig. 1A and B
and were cultivated for 14 days in the presence of IL-4 and GM-CSF. (B)
imDC or mDC (106/ml) were pulsed with HIV-1Ba-L
and cocultivated with T cells (106/ml) for 8 days as
described for Fig. 1D and E. (C) T cells were isolated, infected with
HIV-1Ba-L or HIV-1IIIB, and cultivated as
described for Fig. 1C.
|
|
Next, we investigated the Ag pattern of HIV-1 released from cocultures
of HIV-1
Ba-L-infected DC with syngeneic T cells. As
described above, virus-containing supernatants were used for VCA.
imDC
or mDC were pulsed with Ba-L and added to autologous T cells.
Independently of whether imDC or mDC were used for cocultivation,
(i)
progeny virus bound to the same MAb, and (ii) no significant
difference
was detected with respect to the amount of captured
virus (Fig.
2B).
Compared to Ag patterns on virions derived from
imDC or mDC, HIV-1
released from cocultures showed a completely
different surface Ag
composition: anti-CD1a, anti-CD83, anti-CD11b,
or anti-CD40 Ab failed
to capture virus from coculture experiments.
Instead of these DC
markers, T-cell-specific surface markers like
CD3, CD4, CD5, and CD25
were detected on the virus
surface.
Since the Ag pattern of HIV-1
Ba-L derived from DC-T-cell
conjugates corresponded to a T-cell origin rather than a DC origin,
the
phenotype of HIV-1 derived from primary T cells was analyzed.
In
addition, the T-tropic isolate IIIB was used for infection.
As shown in
Fig.
2C, cell surface markers specific for T lymphocytes
like CD3, CD5,
CD11a, and CD25 could be easily detected, and again,
no virus was
captured with anti-CD1a, anti-CD83, anti-CD11b, anti-CD40,
or anti-CD14
and CD3 MAbs. Compared to the results obtained from
coculture, the Ag
pattern of T-cell-derived virions did not significantly
differ.
Independently of the virus strain, the same Ag pattern
was observed for
HIV-1
Ba-L and HIV-1
IIIB released from T
cells.
Results obtained by VCA revealed that HIV-1 which budded from DC or T
cells was coated with a host-cell-specific spectrum
of surface
molecules. In contrast, HIV-1 derived from DC-T-cell
cocultures
entirely reflected a T-cell-specific phenotype. No
detectable amount of
HIV-1 derived from DC was present in cocultures
with T cells.
Presently, it is still unclear whether T cells become
infected by
transmission of HIV-1 by direct cell-to-cell contact
or by HIV-1 which
is derived from productively infected DC. The
first possibility is
supported by findings showing that blood
DC transmit HIV-1 to
uninfected T cells without being infected
(
5). A similar
mechanism was recently described for the transmission
of HIV-1 from DC
to Mo or macrophages (
21,
22). In both cases,
HIV-1-loaded
DC were cocultured with Mo in the absence of exogenous
cytokines. Other
reports indicate that productive infection of
DC and their ability to
capture virus are mediated through separate
pathways (
3). In
this study, productive infection was reported
to be dependent on the
presence of IL-4, GM-CSF, and coreceptors,
while virus transmission
occurred independently of these factors.
However, it is difficult to
exclude the chance that productive
infection of DC in DC-T-cell
conjugates occurs, since small amounts
of virus are still sufficient
for infection of clustered T cells
(
4,
31,
40). The
observation that HIV-1 does not replicate
in coculture after
pretreatment of DC with zidovudine is a further
indication for a
possible productive infection of DC in cocultures
(
31,
39).
Independent of whether DC are productively infected,
they might provide
additional signals for T-cell activation which
in turn could enhance
virus production by DC. Indeed, HIV-1 production
in virus-pulsed DC was
reported to be potentiated through stimulation
of CD40 (
28,
39,
40).
Infectivity of HIV-1Ba-L derived from DC, DC-T-cell
conjugates, T cells, and PBMC.
To examine the infectivity of
HIV-1Ba-L derived from imDC, mDC, T cells, cocultures of
imDC or mDC with T cells, or PBMC, virus-containing supernatants were
used for infection of IL-2-prestimulated PBMC (20 U/ml). After 10 days
of culture, the 50% tissue culture infectious dose
(TCID50) was calculated for each virus supernatant (ID50 software provided by J. L. Spouge, National
Center for Biotechnology Information, National Institutes of Health)
and given as TCID50 per nanogram of p24 Ag per milliliter.
Virus-containing culture supernatants of respective host cells (2 ng of
p24 Ag/100 µl/well; purified by centrifugation and filtration) were
serially diluted in cRPMI before PBMC were seeded (105
cells/50 µl/well). After overnight incubation at 37°C to allow viral entry, cells were washed three times and fresh medium (cRPMI supplemented with 20 U of IL-2 per ml) was added to a final volume of
200 µl/well. Cells were cultured for 10 days at 37°C before virus
replication was determined by monitoring p24 Ag production. Three
replicates per dilution step were made.
Although productive infection was achieved in all six cases, virus
supernatants differed in their infectivities (Fig.
3).
The most infectious virus was
obtained from cocultures of imDC
with T cells. Cultures of mDC with T
cells released significantly
less infectious virus than did cocultures
of imDC with T cells
(
P < 0.05). Virus released from
imDC or mDC did not show any difference
in infectivity but was
significantly less infectious than HIV-1
derived from imDC-T-cell
cocultures or PBMC or T-cell-derived
virus. No significant differences
in infectivity were observed
for HIV-1 derived from PBMC and that from
T cells. Therefore,
we suggest that, depending on the maturation stage
of DC, different
cytokines might be produced during the interaction
with T cells,
which in turn can influence the infectivity of HIV-1.
Further
studies are necessary to identify the role of soluble factors
in HIV-1 infection.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Infectivity of HIV-1Ba-L isolated from DC, T
cells, DC-T-cell cocultures, and PBMC. HIV-1Ba-L derived
from respective host cells was used for infection of IL-2-stimulated
PBMC. Each virus supernatant (2 ng of p24 Ag/100 µl) was serially
diluted and incubated with target cells (105 cells/well)
for up to 12 h. After overnight incubation at 37°C, cells were
washed and resuspended in cRPMI supplemented with IL-2. At 10 days
postinfection, p24 Ag production was detected by p24 Ag ELISA. The
TCID50 was calculated by Spearman-Kaerber fit. Results
represent the means ± standard errors of the means of two
independent experiments.
|
|
In summary, we demonstrated that MDDC were preferentially infected with
M-tropic HIV-1 isolates and release infectious virus.
On the other
hand, functional analysis revealed that highly infectious
virions
derived from cocultures of imDC with T cells were produced
by T
lymphocytes. Whether DC produce infectious virus in vivo
or transmit
captured virions to T cells remains to be elucidated.
Also, this study
demonstrates that the VCA offers an interesting
approach to analyze the
origin of HIV-1 in vitro and in vivo and
to monitor the course of
infection since the host cell's Ag pattern
is reflected on the viral
envelope.
 |
ACKNOWLEDGMENTS |
We thank Martin Purtscher for providing the human neutralizing MAb
2G12 and Brigitte Müllauer for technical assistance.
This work was supported by the federal state of Tyrol, the Ludwig
Boltzmann Gesellschaft, and the BMAGS.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Hygiene, Leopold-Franzens-Universität, Fritz-Pregl-Str.
3/III, A-6020 Innsbruck, Austria. Phone: 43-512-507-3401. Fax:
43-512-507-2870. E-mail: hygiene{at}uibk.ac.at.
 |
REFERENCES |
| 1.
|
Banchereau, J., and R. M. Steinman.
1998.
Dendritic cells and the control of immunity.
Nature
392:245-252[Medline].
|
| 2.
|
Bender, A.,
M. Sapp,
G. Schuler,
R. M. Steinman, and N. Bhardwaj.
1996.
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.
J. Immunol. Methods
196:121-135[Medline].
|
| 3.
|
Blauvelt, A.,
H. Asada,
M. W. Saville,
V. Klaus Kovtun,
D. J. Altman,
R. Yarchoan, and S. I. Katz.
1997.
Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.
J. Clin. Invest.
100:2043-2053[Medline].
|
| 4.
|
Cameron, P.,
M. Pope,
A. Granelli Piperno, and R. M. Steinman.
1996.
Dendritic cells and the replication of HIV-1.
J. Leukoc. Biol.
59:158-171[Abstract].
|
| 5.
|
Cameron, P. U.,
P. S. Freudenthal,
J. M. Barker,
S. Gezelter,
K. Inaba, and R. M. Steinman.
1992.
Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.
Science
257:383-387. (Erratum, 257:1848.)
|
| 6.
|
Cameron, P. U.,
M. Pope,
S. Gezelter, and R. M. Steinman.
1994.
Infection and apoptotic cell death of CD4+ T cells during an immune response to HIV-1-pulsed dendritic cells.
AIDS Res. Hum. Retroviruses
10:61-71[Medline].
|
| 7.
|
Cella, M.,
A. Engering,
V. Pinet,
J. Pieters, and A. Lanzavecchia.
1997.
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells.
Nature
388:782-787[Medline].
|
| 8.
|
Cella, M.,
F. Sallusto, and A. Lanzavecchia.
1997.
Origin, maturation and antigen presenting function of dendritic cells.
Curr. Opin. Immunol.
9:10-16[Medline].
|
| 9.
|
Charbonnier, A. S.,
B. Verrier,
C. Jacquet,
C. Massacrier,
M. M. Fiers,
F. Mallet,
C. Dezutter Dambuyant, and D. Schmitt.
1996.
In vitro HIV-1 infection of CD34+ progenitor-derived dendritic/Langerhans cells at different stages of their differentiation in the presence of GM-CSF/TNF alpha.
Res. Virol.
147:89-95[Medline].
|
| 10.
|
Dierich, M. P.,
I. Frank,
H. Stoiber,
A. Clivio,
M. Spruth,
F. Steindl, and H. W. Katinger.
1996.
The envelope of HIV.
Immunol. Lett.
54:205-206[Medline].
|
| 11.
|
Feng, Y.,
C. C. Broder,
P. E. Kennedy, and E. A. Berger.
1996.
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
Science
272:872-877[Abstract].
|
| 12.
|
Frank, I.,
H. Stoiber,
S. Godar,
H. Stockinger,
F. Steindl,
H. W. Katinger, and M. P. Dierich.
1996.
Acquisition of host cell-surface-derived molecules by HIV-1.
AIDS
10:1611-1620[Medline].
|
| 13.
|
Frankel, S. S.,
K. Tenner Racz,
P. Racz,
B. M. Wenig,
C. H. Hansen,
D. Heffner,
A. M. Nelson,
M. Pope, and R. M. Steinman.
1997.
Active replication of HIV-1 at the lymphoepithelial surface of the tonsil.
Am. J. Pathol.
151:89-96[Abstract].
|
| 14.
|
Frankel, S. S.,
B. M. Wenig,
A. P. Burke,
P. Mannan,
L. D. Thompson,
S. L. Abbondanzo,
A. M. Nelson,
M. Pope, and R. M. Steinman.
1996.
Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid.
Science
272:115-117[Abstract].
|
| 15.
|
Gelderblom, H. R.,
E. H. Hausmann,
M. Ozel,
G. Pauli, and M. A. Koch.
1987.
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
Virology
156:171-176[Medline].
|
| 15a.
| Granelli-Piperno, A. Personal communication.
|
| 16.
|
Granelli-Piperno, A.,
E. Delgado,
V. Finkel,
W. Paxton, and R. M. Steinman.
1998.
Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells.
J. Virol.
72:2733-2737[Abstract/Free Full Text].
|
| 17.
|
Granelli Piperno, A.,
B. Moser,
M. Pope,
D. Chen,
Y. Wei,
F. Isdell,
U. O'Doherty,
W. Paxton,
R. Koup,
S. Mojsov,
N. Bhardwaj,
I. Clark Lewis,
M. Baggiolini, and R. M. Steinman.
1996.
Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors.
J. Exp. Med.
184:2433-2438[Abstract/Free Full Text].
|
| 18.
|
Granelli-Piperno, A.,
M. Pope,
K. Inaba, and R. M. Steinman.
1995.
Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia.
Proc. Natl. Acad. Sci. USA
92:10944-10948[Abstract/Free Full Text].
|
| 19.
|
Inaba, K.,
J. P. Metlay,
M. T. Crowley, and R. M. Steinman.
1990.
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.
J. Exp. Med.
172:631-640[Abstract/Free Full Text]. (Erratum, 172:1275.)
|
| 20.
|
Joag, S. V.,
I. Adany,
Z. Li,
L. Foresman,
D. M. Pinson,
C. Wang,
E. B. Stephens,
R. Raghavan, and O. Narayan.
1997.
Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS.
J. Virol.
71:4016-4023[Abstract].
|
| 21.
| Kacani, L., I. Frank, M. G. Schwendinger, H. Stoiber, M. Spruth, B. Muellauer, G. M. Sprinzl, F. Steindl, and
M. P. Dierich. Interaction between dendritic cells and
monocytes is mediated through adhesion molecules: implication for HIV-1
transmission. Submitted for publication.
|
| 22.
|
Kacani, L.,
I. Frank,
M. Spruth,
M. G. Schwendinger,
B. Müllauer,
G. M. Sprinzl,
F. Steindl, and M. P. Dierich.
1998.
Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages.
J. Virol.
72:6671-6677[Abstract/Free Full Text].
|
| 23.
|
Liu, L. M., and G. G. MacPherson.
1993.
Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo.
J. Exp. Med.
177:1299-1307[Abstract/Free Full Text].
|
| 24.
|
Mellman, I.,
S. J. Turley, and R. M. Steinman.
1998.
Antigen processing for amateurs and professionals.
Trends Cell Biol.
8:231-237.
[Medline] |
| 25.
|
Orentas, R. J., and J. E. Hildreth.
1993.
Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.
AIDS Res. Hum. Retroviruses
9:1157-1165[Medline].
|
| 26.
|
Palucka, K. A.,
N. Taquet,
F. Sanchez Chapuis, and J. C. Gluckman.
1998.
Dendritic cells as the terminal stage of monocyte differentiation.
J. Immunol.
160:4587-4595[Abstract/Free Full Text].
|
| 27.
|
Pickl, W. F.,
O. Majdic,
P. Kohl,
J. Stockl,
E. Riedl,
C. Scheinecker,
C. Bello Fernandez, and W. Knapp.
1996.
Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
J. Immunol.
157:3850-3859[Abstract].
|
| 28.
|
Pinchuk, L. M.,
P. S. Polacino,
M. B. Agy,
S. J. Klaus, and E. A. Clark.
1994.
The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection.
Immunity
1:317-325[Medline].
|
| 29.
|
Pope, M.,
M. G. Betjes,
N. Romani,
H. Hirmand,
P. U. Cameron,
L. Hoffman,
S. Gezelter,
G. Schuler, and R. M. Steinman.
1994.
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1.
Cell
78:389-398[Medline].
|
| 30.
|
Pope, M.,
S. S. Frankel,
J. R. Mascola,
A. Trkola,
F. Isdell,
D. L. Birx,
D. S. Burke,
D. D. Ho, and J. P. Moore.
1997.
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism.
J. Virol.
71:8001-8007[Abstract].
|
| 31.
|
Pope, M.,
S. Gezelter,
N. Gallo,
L. Hoffman, and R. M. Steinman.
1995.
Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.
J. Exp. Med.
182:2045-2056[Abstract/Free Full Text].
|
| 32.
|
Romani, N.,
D. Reider,
M. Heuer,
S. Ebner,
E. Kampgen,
B. Eibl,
D. Niederwieser, and G. Schuler.
1996.
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.
J. Immunol. Methods
196:137-151[Medline].
|
| 33.
|
Rosenzwajg, M.,
B. Canque, and J. C. Gluckman.
1996.
Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells.
Blood
87:535-544[Abstract/Free Full Text].
|
| 34.
|
Rubbert, A.,
C. Combadiere,
M. Ostrowski,
J. Arthos,
M. Dybul,
E. Machado,
M. A. Cohn,
J. A. Hoxie,
P. M. Murphy,
A. S. Fauci, and D. Weissman.
1998.
Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry.
J. Immunol.
160:3933-3941[Abstract/Free Full Text].
|
| 35.
|
Sallusto, F., and A. Lanzavecchia.
1994.
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
J. Exp. Med.
179:1109-1118[Abstract/Free Full Text].
|
| 36.
|
Samson, M.,
A. L. Edinger,
P. Stordeur,
J. Rucker,
V. Verhasselt,
M. Sharron,
C. Govaerts,
C. Mollereau,
G. Vassart,
R. W. Doms, and M. Parmentier.
1998.
ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains.
Eur. J. Immunol.
28:1689-1700[Medline].
|
| 37.
|
Spira, A. I.,
P. A. Marx,
B. K. Patterson,
J. Mahoney,
R. A. Koup,
S. M. Wolinsky, and D. D. Ho.
1996.
Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.
J. Exp. Med.
183:215-225[Abstract/Free Full Text].
|
| 38.
|
Tremblay, M. J.,
J. F. Fortin, and R. Cantin.
1998.
The acquisition of host-encoded proteins by nascent HIV-1.
Immunol. Today
19:346-351[Medline].
|
| 39.
|
Tsunetsugu-Yokota, Y.,
K. Akagawa,
H. Kimoto,
K. Suzuki,
M. Iwasaki,
S. Yasuda,
G. Hausser,
C. Hultgren,
A. Meyerhans, and T. Takemori.
1995.
Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation.
J. Virol.
69:4544-4547[Abstract].
|
| 40.
|
Tsunetsugu-Yokota, Y.,
S. Yasuda,
A. Sugimoto,
T. Yagi,
M. Azuma,
H. Yagita,
K. Akagawa, and T. Takemori.
1997.
Efficient virus transmission from dendritic cells to CD4+ T cells in response to antigen depends on close contact through adhesion molecules.
Virology
239:259-268[Medline].
|
| 41.
|
Warren, M. K.,
W. L. Rose,
J. L. Cone,
W. G. Rice, and J. A. Turpin.
1997.
Differential infection of CD34+ cell-derived dendritic cells and monocytes with lymphocyte-tropic and monocyte-tropic HIV-1 strains.
J. Immunol.
158:5035-5042[Abstract].
|
| 42.
|
Zhou, L. J., and T. F. Tedder.
1996.
CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.
Proc. Natl. Acad. Sci. USA
93:2588-2592[Abstract/Free Full Text].
|
Journal of Virology, April 1999, p. 3449-3454, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Duvall, M. G., Lore, K., Blaak, H., Ambrozak, D. A., Adams, W. C., Santos, K., Geldmacher, C., Mascola, J. R., McMichael, A. J., Jaye, A., Whittle, H. C., Rowland-Jones, S. L., Koup, R. A.
(2007). Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection. J. Virol.
81: 13486-13498
[Abstract]
[Full Text]
-
Wilflingseder, D., Banki, Z., Garcia, E., Pruenster, M., Pfister, G., Muellauer, B., Nikolic, D. S., Gassner, C., Ammann, C. G., Dierich, M. P., Piguet, V., Stoiber, H.
(2007). IgG Opsonization of HIV Impedes Provirus Formation in and Infection of Dendritic Cells and Subsequent Long-Term Transfer to T Cells. J. Immunol.
178: 7840-7848
[Abstract]
[Full Text]
-
Wahl, S. M., Greenwell-Wild, T., Vazquez, N.
(2006). HIV accomplices and adversaries in macrophage infection. J. Leukoc. Biol.
80: 973-983
[Abstract]
[Full Text]
-
Trapp, S., Turville, S. G., Robbiani, M.
(2006). Slamming the door on unwanted guests: why preemptive strikes at the mucosa may be the best strategy against HIV. J. Leukoc. Biol.
80: 1076-1083
[Full Text]
-
Kolegraff, K., Bostik, P., Ansari, A. A.
(2006). Characterization and role of lentivirus-associated host proteins.. Exp. Biol. Med.
231: 252-263
[Abstract]
[Full Text]
-
Cavrois, M., Neidleman, J., Kreisberg, J. F., Fenard, D., Callebaut, C., Greene, W. C.
(2006). Human Immunodeficiency Virus Fusion to Dendritic Cells Declines as Cells Mature. J. Virol.
80: 1992-1999
[Abstract]
[Full Text]
-
Granelli-Piperno, A., Shimeliovich, I., Pack, M., Trumpfheller, C., Steinman, R. M.
(2006). HIV-1 Selectively Infects a Subset of Nonmaturing BDCA1-Positive Dendritic Cells in Human Blood. J. Immunol.
176: 991-998
[Abstract]
[Full Text]
-
Lore, K., Smed-Sorensen, A., Vasudevan, J., Mascola, J. R., Koup, R. A.
(2005). Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. JEM
201: 2023-2033
[Abstract]
[Full Text]
-
Nair, M. P. N., Mahajan, S. D., Schwartz, S. A., Reynolds, J., Whitney, R., Bernstein, Z., Chawda, R. P., Sykes, D., Hewitt, R., Hsiao, C. B.
(2005). Cocaine Modulates Dendritic Cell-Specific C Type Intercellular Adhesion Molecule-3-Grabbing Nonintegrin Expression by Dendritic Cells in HIV-1 Patients. J. Immunol.
174: 6617-6626
[Abstract]
[Full Text]
-
Yuan, J., Latouche, J.-B., Reagan, J. L., Heller, G., Riviere, I., Sadelain, M., Young, J. W.
(2005). Langerhans Cells Derived from Genetically Modified Human CD34+ Hemopoietic Progenitors Are More Potent Than Peptide-Pulsed Langerhans Cells for Inducing Antigen-Specific CD8+ Cytolytic T Lymphocyte Responses. J. Immunol.
174: 758-766
[Abstract]
[Full Text]
-
Wilflingseder, D., Mullauer, B., Schramek, H., Banki, Z., Pruenster, M., Dierich, M. P., Stoiber, H.
(2004). HIV-1-Induced Migration of Monocyte-Derived Dendritic Cells Is Associated with Differential Activation of MAPK Pathways. J. Immunol.
173: 7497-7505
[Abstract]
[Full Text]
-
de Repentigny, L., Lewandowski, D., Jolicoeur, P.
(2004). Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection. Clin. Microbiol. Rev.
17: 729-759
[Abstract]
[Full Text]
-
Giguere, J.-F., Bounou, S., Paquette, J.-S., Madrenas, J., Tremblay, M. J.
(2004). Insertion of Host-Derived Costimulatory Molecules CD80 (B7.1) and CD86 (B7.2) into Human Immunodeficiency Virus Type 1 Affects the Virus Life Cycle. J. Virol.
78: 6222-6232
[Abstract]
[Full Text]
-
Poudrier, J., Weng, X., Kay, D. G., Hanna, Z., Jolicoeur, P.
(2003). The AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Accumulation of Immature CD11bHi Dendritic Cells. J. Virol.
77: 11733-11744
[Abstract]
[Full Text]
-
Turville, S. G., Arthos, J., Mac Donald, K., Lynch, G., Naif, H., Clark, G., Hart, D., Cunningham, A. L.
(2001). HIV gp120 receptors on human dendritic cells. Blood
98: 2482-2488
[Abstract]
[Full Text]
-
Speth, C., Stöckl, G., Mohsenipour, I., Würzner, R., Stoiber, H., Lass-Flörl, C., Dierich, M. P.
(2001). Human Immunodeficiency Virus Type 1 Induces Expression of Complement Factors in Human Astrocytes. J. Virol.
75: 2604-2615
[Abstract]
[Full Text]
-
Gratton, S., Cheynier, R., Dumaurier, M.-J., Oksenhendler, E., Wain-Hobson, S.
(2000). Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc. Natl. Acad. Sci. USA
97: 14566-14571
[Abstract]
[Full Text]
-
Lawn, S. D., Roberts, B. D., Griffin, G. E., Folks, T. M., Butera, S. T.
(2000). Cellular Compartments of Human Immunodeficiency Virus Type 1 Replication In Vivo: Determination by Presence of Virion-Associated Host Proteins and Impact of Opportunistic Infection. J. Virol.
74: 139-145
[Abstract]
[Full Text]
-
Mummidi, S., Catano, G., Lam, L., Hoefle, A., Telles, V., Begum, K., Jimenez, F., Ahuja, S. S., Ahuja, S. K.
(2001). Extensive Repertoire of Membrane-bound and Soluble Dendritic Cell-specific ICAM-3-grabbing Nonintegrin 1 (DC-SIGN1) and DC-SIGN2 Isoforms. INTER-INDIVIDUAL VARIATION IN EXPRESSION OF DC-SIGN TRANSCRIPTS. J. Biol. Chem.
276: 33196-33212
[Abstract]
[Full Text]